Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. (RNAC) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 73 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Dec 16, 2025 involved a transaction of 5,800 shares valued at $0.
RNAC Insider Activity Summary
Who Is Buying RNAC Stock?
No significant insider buying has been recorded for RNAC in the recent period.
Who Is Selling RNAC Stock?
No significant insider selling has been recorded for RNAC in the recent period.
Is Cartesian Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RNAC is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RNAC Frequently Asked Questions
Understanding RNAC Insider Activity
Insider trading at Cartesian Therapeutics, Inc. (RNAC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading RNAC stock, having executed 73 transactions in the past 90 days. The most active insider is Timothy A. Springer (Executive), who has made 31 transactions totaling $110.9M.
Related Tools
Track Cartesian Therapeutics, Inc. Insider Activity
Get notified when executives and directors at RNAC file new Form 4 transactions